Pharmaceutical-grade albumin: impaired drug-binding capacity in vitro

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1472-6904

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Pharmaceutical-grade albumin: impaired drug-binding capacity in vitro ; volume:4 ; number:1 ; day:29 ; month:3 ; year:2004 ; pages:1-9 ; date:12.2004
BMC clinical pharmacology ; 4, Heft 1 (29.3.2004), 1-9, 12.2004

Creator: Olsen, Harald

Contributor: Andersen, Anders
Nordbø, Arve
Kongsgaard, Ulf E.
Børmer, Ole P.
SpringerLink (Online service)

DOI: 10.1186/1472-6904-4-4

URN: urn:nbn:de:1111-2016072029854

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:47 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Olsen, Harald
Andersen, Anders
Nordbø, Arve
Kongsgaard, Ulf E.
Børmer, Ole P.
SpringerLink (Online service)

Other Objects (12)

Impaired functional capacity of polarised neonatal macrophages

Influence of arousal on intentional binding: Impaired action binding, intact outcome binding

Ischemia – modified albumin by albumin cobalt binding test: a false myth or reality

Resolving Binding Events on the Multifunctional Human Serum Albumin

Resolving binding events on the multifunctional human serum albumin

Absence of the CXCR4 antagonist EPI‑X4 from pharmaceutical human serum albumin preparations

Absence of the CXCR4 antagonist EPI-X4 from pharmaceutical human serum albumin preparations

Optimizing the pharmacokinetics of an 211At-labeled RGD peptide with an albumin-binding moiety via the administration of an albumin-binding inhibitor

Pharmaceutical mobile application for visually-impaired people in Thailand: development and implementation

The influence of various aminoglycoside preparations on bilirubin/albumin binding

The scavenging capacity of DMBT1 is impaired by germline deletions

Albumin-binding photosensitizer capable of targeting glioma via the SPARC pathway

Impaired functional capacity of polarised neonatal macrophages

Influence of arousal on intentional binding: Impaired action binding, intact outcome binding

Ischemia – modified albumin by albumin cobalt binding test: a false myth or reality

Resolving Binding Events on the Multifunctional Human Serum Albumin

Resolving binding events on the multifunctional human serum albumin

Absence of the CXCR4 antagonist EPI‑X4 from pharmaceutical human serum albumin preparations

Absence of the CXCR4 antagonist EPI-X4 from pharmaceutical human serum albumin preparations

Optimizing the pharmacokinetics of an 211At-labeled RGD peptide with an albumin-binding moiety via the administration of an albumin-binding inhibitor

Pharmaceutical mobile application for visually-impaired people in Thailand: development and implementation

The influence of various aminoglycoside preparations on bilirubin/albumin binding

The scavenging capacity of DMBT1 is impaired by germline deletions

Albumin-binding photosensitizer capable of targeting glioma via the SPARC pathway

Impaired functional capacity of polarised neonatal macrophages

Influence of arousal on intentional binding: Impaired action binding, intact outcome binding

Ischemia – modified albumin by albumin cobalt binding test: a false myth or reality

Resolving Binding Events on the Multifunctional Human Serum Albumin

Resolving binding events on the multifunctional human serum albumin

Absence of the CXCR4 antagonist EPI‑X4 from pharmaceutical human serum albumin preparations

Absence of the CXCR4 antagonist EPI-X4 from pharmaceutical human serum albumin preparations

Optimizing the pharmacokinetics of an 211At-labeled RGD peptide with an albumin-binding moiety via the administration of an albumin-binding inhibitor

Pharmaceutical mobile application for visually-impaired people in Thailand: development and implementation

The influence of various aminoglycoside preparations on bilirubin/albumin binding

The scavenging capacity of DMBT1 is impaired by germline deletions

Albumin-binding photosensitizer capable of targeting glioma via the SPARC pathway

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Pharmaceutical-grade albumin: impaired drug-binding capacity in vitro

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Impaired functional capacity of polarised neonatal macrophages

Influence of arousal on intentional binding: Impaired action binding, intact outcome binding

Ischemia – modified albumin by albumin cobalt binding test: a false myth or reality

Resolving Binding Events on the Multifunctional Human Serum Albumin

Resolving binding events on the multifunctional human serum albumin

Absence of the CXCR4 antagonist EPI‑X4 from pharmaceutical human serum albumin preparations

Absence of the CXCR4 antagonist EPI-X4 from pharmaceutical human serum albumin preparations

Optimizing the pharmacokinetics of an 211At-labeled RGD peptide with an albumin-binding moiety via the administration of an albumin-binding inhibitor

Pharmaceutical mobile application for visually-impaired people in Thailand: development and implementation

The influence of various aminoglycoside preparations on bilirubin/albumin binding

The scavenging capacity of DMBT1 is impaired by germline deletions

Albumin-binding photosensitizer capable of targeting glioma via the SPARC pathway

Impaired functional capacity of polarised neonatal macrophages

Influence of arousal on intentional binding: Impaired action binding, intact outcome binding

Ischemia – modified albumin by albumin cobalt binding test: a false myth or reality

Resolving Binding Events on the Multifunctional Human Serum Albumin

Resolving binding events on the multifunctional human serum albumin

Absence of the CXCR4 antagonist EPI‑X4 from pharmaceutical human serum albumin preparations

Absence of the CXCR4 antagonist EPI-X4 from pharmaceutical human serum albumin preparations

Optimizing the pharmacokinetics of an 211At-labeled RGD peptide with an albumin-binding moiety via the administration of an albumin-binding inhibitor

Pharmaceutical mobile application for visually-impaired people in Thailand: development and implementation

The influence of various aminoglycoside preparations on bilirubin/albumin binding

The scavenging capacity of DMBT1 is impaired by germline deletions

Albumin-binding photosensitizer capable of targeting glioma via the SPARC pathway

Impaired functional capacity of polarised neonatal macrophages

Influence of arousal on intentional binding: Impaired action binding, intact outcome binding

Ischemia – modified albumin by albumin cobalt binding test: a false myth or reality

Resolving Binding Events on the Multifunctional Human Serum Albumin

Resolving binding events on the multifunctional human serum albumin

Absence of the CXCR4 antagonist EPI‑X4 from pharmaceutical human serum albumin preparations

Absence of the CXCR4 antagonist EPI-X4 from pharmaceutical human serum albumin preparations

Optimizing the pharmacokinetics of an 211At-labeled RGD peptide with an albumin-binding moiety via the administration of an albumin-binding inhibitor

Pharmaceutical mobile application for visually-impaired people in Thailand: development and implementation

The influence of various aminoglycoside preparations on bilirubin/albumin binding

The scavenging capacity of DMBT1 is impaired by germline deletions

Albumin-binding photosensitizer capable of targeting glioma via the SPARC pathway

Related objects

Reset password